Download
https://www.ndtvprofit.com/business/us-fda-conducts-surprise-audit-at-cadilas-moraiya-plant?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The inspection was done due to multiple recall of product recall of a drug in 2017 and issues of stability failure.
Share